持續性膀胱沖洗裝置市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、最終用戶、地區和競爭對手分類，2021-2031年

全球持續膀胱沖洗裝置市場預計將從 2025 年的 14.9 億美元成長到 2031 年的 19.1 億美元，複合年成長率為 4.23%。

這些專用醫療系統對於確保膀胱穩定供應無菌生理食鹽水至關重要，其主要作用是預防血栓形成，並在經尿道前列腺切除術等泌尿系統手術後維持導尿管通暢性。市場成長的根本促進因素是全球泌尿系統疾病（例如良性前列腺增生）盛行率的上升，這些疾病需要頻繁的手術干預；以及老年人口的成長，老年人尤其容易受到需要灌注治療才能安全術後恢復的疾病的影響。

近期疾病發病率統計數據有力地支持了對這些臨床解決方案的需求。美國癌症協會估計，2024年美國將新增83,190例膀胱癌病例，凸顯了有效術後管理工具的迫切需求。然而，由於導尿管相關尿道感染的風險，市場面臨許多挑戰。嚴格的感染控制要求以及院內感染可能引發的併發症構成了一項重大挑戰，可能會限制這些沖洗裝置在醫療機構中的長期使用。

市場促進因素

市場成長的主要驅動力是老年人口的快速成長，因為老化與良性前列腺增生（BPH）之間存在密切關聯。隨著男性年齡的成長，罹患BPH的幾率顯著增加，導致需要進行經尿道前列腺切除術（TURP）等手術的人數上升。這些手術需要持續膀胱灌注，以預防血尿併發症並維持導尿管的通暢。這一人口趨勢保證了對灌注系統的穩定需求，2024年7月AUANews的一篇報導指出“BPH影響著大約60%的60歲以上男性和幾乎所有80歲以上的男性”，形成了大規模的泌尿系統護理患者群體。

同時，由於診斷率的提高和疫情後手術延誤的消除，泌尿系統手術量增加，也推動了市場成長。膀胱癌和攝護腺疾病等疾病手術量的增加，直接導致醫院沖洗液和導尿管系統的日常使用量增加。例如，英國前列腺癌協會在2024年4月發布的報告顯示，與疫情前相比，2022年3月至2023年2月期間，英格蘭的泌尿系統系統癌症治療數量增加了8.5%。手術量的激增正在推動製造商的收入成長。科樂普公司2024年的財務表現也顯示，其介入泌尿外科部門實現了5%的內部成長，這主要得益於男性健康和內視鏡泌尿系統領域的持續需求。

市場挑戰

持續性膀胱沖洗裝置全球市場的主要障礙是導尿管相關尿道感染（CAUTI）的持續威脅。由於持續沖洗依賴留置導尿管，長期使用會促進細菌定植，增加患者的感染風險。這迫使醫療機構實施嚴格的「拔管」通訊協定和合理使用抗生素的計劃，要求儘早拔除導尿管。這些臨床實踐直接限制了沖洗治療的持續時間，導致一次性沖洗裝置和無菌沖洗液的使用量減少。這對製造商的持續收入產生了負面影響。

此外，治療醫院感染所帶來的經濟負擔迫使醫療機構管理者限制侵入性技術的使用。醫院往往需要為可預防的感染疾病承擔自付費用，而長期使用體外循環設備也會帶來經濟風險。根據2024年APIC的數據，導管相關感染疾病佔所有醫療相關感染疾病的30%以上，這迫使醫療機構盡量減少對這些設備的依賴，以避免高昂的感染控制成本。這正在減緩市場成長。

市場趨勢

智慧感測器在即時血流監測中的應用，滿足了精準液體管理和自動血栓檢測的需求，顯著推動了市場發展。這些基於感測器的系統持續分析顏色和流量等流出指標，並自動調節灌注速率，從而防止導管阻塞和膀胱過度充盈，同時最大限度地減少手動調節帶來的誤差。 2024年10月發表於《泌尿系統雜誌》的一項研究證實了該技術的臨床價值。接受整合式感測器設備治療的患者平均住院時間為3.3天，顯著短於標準治療的3.6天，凸顯了這些智慧解決方案的高效性和安全性優勢。

同時，對嚴格的感染控制通訊協定和運作效率的需求正推動一次性沖洗裝置的日益普及。醫療機構正轉向完全一次性系統，以消除重複使用部件帶來的交叉感染風險，並透過簡化複雜的再處理流程來簡化術後工作流程。這一轉變在該領域強勁的市場趨勢中顯而易見。例如，Ambu A/S 的 2023/24 年度報告顯示，其內視鏡解決方案業務（包括一次性泌尿系統）的有機收入成長率為 19.7%，顯示市場對一次性介入技術的需求強勁。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球持續性膀胱沖洗裝置市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品細分（Foley 三腔導尿管（矽膠導尿管、乳膠導尿管）、沖洗袋、配件（沖洗器、滾輪夾、排放袋））
  • 依最終使用者（醫院/診所、門診護理中心、其他）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美持續性膀胱沖洗裝置市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲持續膀胱沖洗裝置市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區持續膀胱沖洗裝置市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲持續膀胱沖洗裝置的市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲持續膀胱沖洗裝置的市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球持續性膀胱沖洗裝置市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Sterimed Group
• Angiplast pvt. ltd.
• Advin Health Care
• AdvaCare Pharma
• Teleflex Incorporated
• BACTIGUARD AB
• VOGT MEDICAL
• CR Bard
• Coloplast Corp
• Hospital Equipment Manufacturing Company
• Baxter Internationals

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Continuous Bladder Irrigation Devices Market is projected to expand from USD 1.49 billion in 2025 to USD 1.91 billion by 2031, reflecting a compound annual growth rate of 4.23%. These specialized medical systems are essential for delivering a steady stream of sterile saline into the bladder, primarily to prevent clot retention and ensure catheter patency after urological surgeries like Transurethral Resection of the Prostate. Market growth is fundamentally driven by the rising global prevalence of urological disorders, such as Benign Prostatic Hyperplasia, which demand frequent surgical interventions, alongside an expanding geriatric population that is particularly vulnerable to conditions requiring postoperative irrigation for safe recovery.

Recent statistics on disease incidence strongly underpin the demand for these clinical solutions, with the American Cancer Society estimating 83,190 new bladder cancer diagnoses in the United States for 2024, highlighting the critical need for effective postoperative management tools. However, the market faces significant hurdles due to the risk of catheter-associated urinary tract infections. Strict infection control requirements and the potential for hospital-acquired complications present a major challenge that may restrict the prolonged usage of these irrigation devices within healthcare facilities.

Market Driver

A primary factor driving market growth is the rapid expansion of the geriatric population, given the strong correlation between aging and Benign Prostatic Hyperplasia (BPH). As men age, the likelihood of prostate enlargement increases significantly, often necessitating surgeries like Transurethral Resection of the Prostate (TURP), where continuous bladder irrigation is mandatory to prevent hematuria complications and maintain catheter flow. This demographic trend ensures a steady baseline demand for irrigation systems, a reality supported by an AUANews article from July 2024 stating that BPH affects approximately 60% of men in their 60s and nearly all men aged 80 and above, creating a large patient base needing urological care.

Simultaneously, the market is bolstered by an increasing volume of urological procedures, fueled by better diagnostic rates and the resolution of post-pandemic surgical backlogs. The rise in surgeries for conditions like bladder cancer and prostate disorders directly increases the daily usage of irrigation fluids and catheter systems in hospitals; for example, Prostate Cancer UK reported in April 2024 that urological cancer treatments in England rose by 8.5% between March 2022 and February 2023 compared to pre-pandemic levels. This surge in procedural activity translates into revenue growth for manufacturers, as seen in Coloplast's 2024 financial results, where their Interventional Urology division achieved 5% organic growth due to sustained demand in men's health and endourology.

Market Challenge

The major obstacle hindering the Global Continuous Bladder Irrigation Devices Market is the persistent threat of catheter-associated urinary tract infections (CAUTIs). Because continuous irrigation relies on indwelling catheters, extended usage facilitates bacterial colonization and heightens patient vulnerability, prompting healthcare institutions to enforce strict "catheter-off" protocols and antibiotic stewardship programs that require early device removal. These clinical practices directly limit the duration of irrigation therapy, subsequently reducing the volume of disposable sets and sterile fluids used, which negatively impacts manufacturers' recurring revenue streams.

Additionally, the financial burden of treating hospital-acquired conditions compels medical administrators to restrict the use of invasive technologies. Hospitals often face non-reimbursement penalties for preventable infections, making prolonged irrigation device usage a financial liability. Data from the Association for Professionals in Infection Control and Epidemiology in 2024 indicated that catheter-associated infections accounted for over 30% of all healthcare-associated infections, forcing providers to minimize reliance on these devices to avoid significant infection management costs, thereby slowing market expansion.

Market Trends

The integration of smart sensors for real-time flow monitoring is significantly advancing the market by fulfilling the need for precise fluid management and automated clot detection. These sensor-based systems continuously analyze outflow metrics such as color and volume to automatically adjust irrigation rates, helping to prevent catheter blockage and bladder overdistension while minimizing errors associated with manual regulation. A study published in the Urology Journal in October 2024 demonstrated the clinical value of this technology, showing that patients treated with sensor-integrated devices had a significantly shorter hospital stay of 3.3 days compared to 3.6 days for standard care, highlighting the efficiency and safety benefits of these intelligent solutions.

Concurrently, there is a growing trend toward the adoption of single-use and disposable irrigation sets, driven by strict infection control protocols and a desire for operational efficiency. Healthcare facilities are increasingly moving to fully disposable systems to eliminate cross-contamination risks linked to reusable components and to simplify postoperative workflows by removing complex reprocessing logistics. This shift is evidenced by strong market performance in this sector, such as Ambu A/S reporting 19.7% organic revenue growth in its Endoscopy Solutions division-which includes single-use urology devices-in their 2023/24 annual report, signaling robust demand for disposable interventional technologies.

Key Market Players

• Sterimed Group
• Angiplast pvt. ltd.
• Advin Health Care
• AdvaCare Pharma
• Teleflex Incorporated
• BACTIGUARD AB
• VOGT MEDICAL
• C. R. Bard
• Coloplast Corp
• Hospital Equipment Manufacturing Company
• Baxter Internationals

Report Scope

In this report, the Global Continuous Bladder Irrigation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Continuous Bladder Irrigation Devices Market, By Product

• Foley 3 Way Catheters(Silicone Catheters, Latex Catheters)
• Irrigation Bags
• Accessories (Irrigation Set, Roller Clamp, Outlet Bags)

Continuous Bladder Irrigation Devices Market, By End user

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Continuous Bladder Irrigation Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Continuous Bladder Irrigation Devices Market.

Available Customizations:

Global Continuous Bladder Irrigation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Continuous Bladder Irrigation Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Foley 3 Way Catheters(Silicone Catheters, Latex Catheters), Irrigation Bags, Accessories (Irrigation Set, Roller Clamp, Outlet Bags))
  • 5.2.2. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Continuous Bladder Irrigation Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End user
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Continuous Bladder Irrigation Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End user
  • 6.3.2. Canada Continuous Bladder Irrigation Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End user
  • 6.3.3. Mexico Continuous Bladder Irrigation Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End user

7. Europe Continuous Bladder Irrigation Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End user
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End user
  • 7.3.2. France Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End user
  • 7.3.3. United Kingdom Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End user
  • 7.3.4. Italy Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End user
  • 7.3.5. Spain Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End user

8. Asia Pacific Continuous Bladder Irrigation Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End user
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End user
  • 8.3.2. India Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End user
  • 8.3.3. Japan Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End user
  • 8.3.4. South Korea Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End user
  • 8.3.5. Australia Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End user

9. Middle East & Africa Continuous Bladder Irrigation Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End user
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Continuous Bladder Irrigation Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End user
  • 9.3.2. UAE Continuous Bladder Irrigation Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End user
  • 9.3.3. South Africa Continuous Bladder Irrigation Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End user

10. South America Continuous Bladder Irrigation Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End user
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Continuous Bladder Irrigation Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End user
  • 10.3.2. Colombia Continuous Bladder Irrigation Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End user
  • 10.3.3. Argentina Continuous Bladder Irrigation Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Continuous Bladder Irrigation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sterimed Group
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Angiplast pvt. ltd.
• 15.3. Advin Health Care
• 15.4. AdvaCare Pharma
• 15.5. Teleflex Incorporated
• 15.6. BACTIGUARD AB
• 15.7. VOGT MEDICAL
• 15.8. C. R. Bard
• 15.9. Coloplast Corp
• 15.10. Hospital Equipment Manufacturing Company
• 15.11. Baxter Internationals

16. Strategic Recommendations

17. About Us & Disclaimer